Curtis Gale Oltmans is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 49,020 shares of ATXI, which is worth approximately $96,569. The most recent transaction as insider was on Dec 17, 2021, when has been sold 49,020 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49K
0% 3M change
0% 12M change
Total Value Held $96,569

Curtis Gale Oltmans Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2021
BUY
Grant, award, or other acquisition
-
49,020 Added 50.0%
49,020 Common Stock

Also insider at

FULC
Fulcrum Therapeutics, Inc. Healthcare
CGO

Curtis Gale Oltmans

Director
Cambridge, MA

Track Institutional and Insider Activities on ATXI

Follow AVENUE THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXI shares.

Notify only if

Insider Trading

Get notified when an Avenue Therapeutics, Inc. insider buys or sells ATXI shares.

Notify only if

News

Receive news related to AVENUE THERAPEUTICS, INC.

Track Activities on ATXI